Submission of intimation of appointment of Directors.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Novelix Pharmaceuticals (formerly Trimurthi Limited) has appointed two new directors to its board with effect from 14th August 2025. Mr. Gattu Gnana Prakash joins as an Additional Non-Executive Non-Independent Director, while Ms. Mayuri Baidya joins as an Additional Non-Executive Independent Director, subject to shareholder approval. Mr. Prakash is an IIT-Chennai graduate with over 25 years of experience in management and IT. Ms. Baidya holds a Post Graduate degree in Commerce from the University of Rajasthan and has experience in accounting and finance. Both appointments are until the next Annual General Meeting, and neither appointee is related to existing directors, KMPs, or promoters, nor debarred by SEBI.
This is a routine board expansion that adds an independent director, which is generally positive for governance. For retail investors, this strengthens board oversight but is unlikely to have any immediate material impact on the stock price.